Laurion Capital Management LP Deciphera Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $3.73 Million - $4.77 Million	274,634 New	274,634 $4.32 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $919,290 - $1.41 Million	-100,910 Reduced 21.97%	358,380 $4.71 Million
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $3.16 Million - $5.1 Million	459,290 New	459,290 $4.26 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $3.02 Million - $5.3 Million	-81,500 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $2.74 Million - $5.66 Million	81,500 New	81,500 $3.36 Million
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $214,230 - $405,779	-11,228 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$33.57 - $42.1 $4.76 Million - $5.97 Million	-141,739 Reduced 92.66%	11,228 $435,000
Q2 2018 Aug 13, 2018	BUY	$20.06 - $44.95 $3.07 Million - $6.88 Million	152,967 New	152,967 $6.02 Million
Q1 2018 May 14, 2018	SELL	$20.04 - $29.71 $4.36 Million - $6.47 Million	-217,800 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$16.54 - $24.2 $119,088 - $174,240	-7,200 Reduced 3.2%	217,800 $4.94 Million
Q3 2017 Nov 13, 2017	BUY	$17.65 - $18.99 $3.97 Million - $4.27 Million	225,000	225,000 $4.27 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.